Price rise for drug outpaces inflation
Article Abstract:
The studies conducted by the 35-million-member retiree group AARP and the consumer group Families USA reported an increase in prices of brand name prescription drugs at more than three times the rates in 2003. The AARP study found that prices increased at an average 6.9 percent for nearly 200 drugs and the increase will negate the value of the discounts available through Medicare's new drug cards.
Publication Name: Philadelphia Inquirer (PA)
Subject: Business, regional
ISSN: 0885-6613
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
FDA expands uses for sleep medication
Article Abstract:
Cephalon Inc. approval to sell its narcolepsy drug, Provigil by the U.S. Food and Drug Administration is approved only for those who suffer from narcolepsy, a disorder in which people suddenly fall sleep during waking hours. The company may promote Provigil on direct-to-consumer television advertising on order to reach shift workers and those suffering from sleep apnea.
Publication Name: Philadelphia Inquirer (PA)
Subject: Business, regional
ISSN: 0885-6613
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Growing firms with huge potential
Article Abstract:
Several Philadelphia-based drug and biotechnology firms have been producing high levels of patents for new products. The firms, according to a new report by the U.S. Small Business Administration, were studied to determine the relationship between patents and company profitability.
Publication Name: Philadelphia Inquirer (PA)
Subject: Business, regional
ISSN: 0885-6613
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Vaccine cuts cases linked to a cancer. Pfizer expands access to discounts
- Abstracts: HomeLife Furniture Corp. will not resume operations. Steel firm files for Chapter 11 shelter. Excite@Home users may lose Internet link
- Abstracts: Airport promises clear sky for future. Acme rings up a small gain. Satisfying city's hunger for suburblike grocers
- Abstracts: Later Vanguard trading deadline draws criticism. Vanguard's tight fists may choke its growth.. Vanguard fights to increase rollover business